[Long-term treatment concepts for osteoporosis]
Barbara Obermayer-Pietsch1, Ines Fössl2, Hans Peter Dimai2
1Klin. Abteilung Endokrinologie und Diabetologie, Univ. Klinik für Innere Medizin, Medizinische Universität Graz, Auenbruggerplatz 15, 8036, Graz, Österreich. Barbara.obermayer@medunigraz.at.
Long-term osteoporosis treatment faces challenges with patient compliance and side effects. This review covers current drugs, guidelines, monitoring, and future directions for managing osteoporosis effectively.
Area of Science:
- Pharmacology
- Bone Metabolism
- Geriatric Medicine
Background:
- Osteoporosis requires long-term pharmacological treatment.
- Patient compliance and severe side effects are significant concerns.
- Guidelines and prescribers focus on effective, safe osteoporosis management.
Purpose of the Study:
- To review current pharmacological treatments for osteoporosis.
- To summarize evidence-based guidelines for long-term osteoporosis management.
- To discuss monitoring, treatment adjustments, and future developments.
Main Methods:
- Literature review of pharmacological agents for osteoporosis.
- Analysis of current clinical guidelines for osteoporosis treatment.
- Synthesis of information on monitoring and treatment modification strategies.
Main Results:
- Current treatments for osteoporosis include bisphosphonates, denosumab, teriparatide, and others.
- Guidelines emphasize individualized treatment based on fracture risk.
- Monitoring involves bone mineral density scans and biochemical markers.
Conclusions:
- Optimizing long-term osteoporosis treatment requires balancing efficacy with safety and compliance.
- Future research should focus on novel therapeutic targets and personalized treatment approaches.
- Adherence to guidelines and proactive monitoring are crucial for preventing fractures.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
03:56Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Venous Thrombosis III: Interprofessional Care
